Differences in results of breast cancer curative treatment between urban/rural female population in Podlaskie Voivodship of Poland before introduction of the National Cancer Control Programme

• Autorzy: Maslach D. , Krzyzak M. , Szpak A. , Owoc A. , Gebska-Kuczerowska A. , Bielska-Lasota M.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to evaluate differences in the results of the curative treatment received by women with breast cancer in urban and rural area in Podlaskie Voivodship in 2001-2002 before the introduction of the National Cancer Control Programme. The analysis was based on 449 women with breast cancer, who received curative treatment in years 2001-2002. Relative 5-year survival rates as function of age and stage among urban and rural women population were calculated. The results showed that survival rates in Podlaskie Voivodship among curatively treated women with breast cancer were 81.9% but they differed between urban and rural areas. Patients living in rural areas had much lower survivals than those living in urban areas at local and regional stage of disease. In all age groups considered in the study survivals in rural areas were lower than in urban ones in which survivals were higher in 55-64 age group. These results indicated the necessity intervention in order to increase the access to the health care system and effectiveness of early detection and also improved treatment standards for more disadvantaged rural areas. These results should be also considered in monitoring of the National Cancer Control Programme introduction in Poland in 2006.

• Wydawca: -
• Czasopismo: Annals of Agricultural and Environmental Medicine
• Rocznik: 2013
• Tom: 20
• Numer: 1
• Opis fizyczny: p.68-71,fig.,ref.

Twórcy

autor

Maslach D.

• Department of Public Health, Medical University, Bialystok, Poland

autor

Krzyzak M.

• Department of Public Health, Medical University, Bialystok, Poland

autor

Szpak A.

• Department of Public Health, Medical University, Bialystok, Poland

autor

Owoc A.

• Lubuski College of Public Health, Zielona Gora, Poland

autor

Gebska-Kuczerowska A.

• National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland

autor

Bielska-Lasota M.

• National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland

Bibliografia

• 1. Micheli A, Baili P. Information on cancer. In: Coleman MP. (Ed) Responding to the challenge of cancer in Europe. Institute of PublicHealth of the Republic of Slovenia 2008: 177-189.
• 2. Berrino F, Capocaccia R. Survival of European cancer patients. In: Coleman MP. (Ed) Responding to the challenge of cancer in Europe.Institute of Public Health of the Republic of Slovenia 2008: 151-175.
• 3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide:IARC CancerBase No. 10 [Internet]. Lyon, France: International Agencyfor Research on Cancer, 2010.
• 4. Wojciechowska U, Didkowska J, Zatoński W. Nowotwory złośliwe w Polsce w 2008 roku. Centrum Onkologii Instytut im. M. Skłodowskiej-Curie, Warszawa 2010.
• 5. Jassem J. Rak piersi. [In:] Zalecenia postępowania diagnostycznoterapeutycznego w nowotworach złośliwych. Vol. I. Krzakowski M.[ed.]. Onkologia w Praktyce Klinicznej 2007; 3 suppl. C: 179-222.
• 6. Gericke Ch. Health Systems in Transition: Poland. WHO Regional Office for Europe on behalf of the European Observatory on HealthSystems and Policies, Copenhagen 2005.
• 7. Wojtyniak B, Goryński P. Stan zdrowia ludności Polski. Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny. Warszawa2008.
• 8. International Statistical Classification of Diseases and Health Related Problems: tenth revision – 2nd edition, World Health Organization,Geneva 2004.
• 9. EUROCARE Working Group: EUROCARE-4 Protocol for Europe- Wide Cancer Survival Study. EUROCARE study web-site: http://www.eurocare.it/Portals/0/Protocols/EUROCARE4protocol4Nov04.pdf(access: 2009.10.25).
• 10. TERYT Krajowy Rejestr Urzędowy Podziału Terytorialnego Kraju [Internet]. Główny Urząd Statystyczny: http://www.stat.gov.pl/broker/access/definitionTree.jspa (access: 2010.02.15).
• 11. Esteban D, Whelan S, Laudico A, Parkin DM. Manual for Cancer Registry Personnel. International Agency for Research on Cancer,Lyon 1995.
• 12. Pohar M, Stare J. Making relative survival analysis relatively easy. Comput Biol Med. 2007; 37: 1741-1749.
• 13. Pohar M, Stare J. Relative survival analysis in R. Comput Programs Biomed. 2006; 81: 272-278.
• 14. Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Comput Programs Biomed. 1985; 19: 197-207.
• 15. Micheli A, Capocaccia R, Martinez C, Mugno E, Coebergh J, Baili P, Verdecchia A, Berrino F, Coleman MP. Cancer control in Europe: aproposed set of European cancer health indicators. Eur J Public Health.2003; 13(suppl. 3): 116-118.
• 16. Krzyżak M, Maślach D, Bielska-Lasota M, Juczewska M, Rabczenko D, Marcinkowski JT, Szpak A. Breast cancer survival gap between urbanand rural female population in Podlaskie Voivodship, Poland, in 2001-2002. Population study. Ann Agric Environ Med. 2010; 17: 277-282.
• 17. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, the EUROCARE Working Group EUROCARE-4. Survival of cancerpatients diagnosed in 1995–1999. Results and commentary. Eur JCancer. 2009; 45: 931–991.
• 18. Verdecchia A, Mariano Santaquilani M, Sant M. Survival for cancer patients in Europe. Ann Ist Super Sanità. 2009; 45(3): 315-324.
• 19. Rocznik Statystyczny Województwa Podlaskiego 2002,Urząd Statystyczny w Białymstoku, Białystok 2003.
• 20. Krzyżak M, Maślach D, Juczewska M, Lasota W, Rabczenko D, Marcinkowski JT, Szpak A. Differences in breast cancer incidenceand stage distribution between urban and rural female population inPodlaskie Voivodship, Poland in years 2001-2002. Ann Agric EnvironMed. 2010; 17: 159-162.
• 21. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J, Youngson J,Berrino F and EUROCARE Working Group. Stage at diagnosis is akey explanation of differences in breast cancer survival across Europe.Int J Cancer. 2003; 1: 416-422.
• 22. Główny Urząd Statystyczny: Charakterystyka obszarów wiejskich. Urząd Statystyczny w Olsztynie, Olsztyn 2004.
• 23. Adams J, White M, Forman D. Are there socioeconomic gradients in stage and grade of breast cancer at diagnosis? Cross sectional analysis of UK cancer registry data. BMJ 2004; 329: 142-143.
• 24. Carlsen K, Høybye MT, Dalton SO, Tjønneland A. Social inequality and incidence of and survival from breast cancer in a population-basedstudy in Denmark, 1994–2003. Eur J Cancer. 2008; 44: 1996-2002.
• 25. Kogevinas M, Pearce N, Susser M, Boffetta P. Social Inequalities and Cancer. IARC Scientific Publication No. 138. International Agency for Research on Cancer, Lyon 1997.
• 26. Mariotto A, Capocaccia R, Verdecchia A, Micheli A, Feuer EJ, Pickle L, Clegg LX. Projecting SEER cancer survival rates to the US: an ecologicalregression approach. Cancer Causes Control. 2002; 13: 101-111.
• 27. Menvielle G, Kunst A. Social inequalities in cancer incidence and cancer survival: Lessons from Danish studies. Eur J Cancer. 2008;44: 1933-1937.
• 28. Newman LA, Martin IK. Disparities in breast cancer. Curr Probl Cancer. 2007; 31: 134-56.
• 29. Yu XQ, O’Connell DL, Gibberd RW, Armstrong BK. Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996–2001. Cancer Causes Control. 2008; 19: 1383–1390.

Uwagi

rekord w opracowaniu